Cited by 5Ear Surgery and Otitis MediaPediatric health and respiratory diseasesSinusitis and nasal conditions

Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: a randomized controlled trial

Open access
Bagher Rahmati, Mohammad, Safdarian, Fatemeh, Shiroui, Babak, Zare, Shahram, Sadeghi, Naser·2017·Electronic Physician

Abstract

BACKGROUND: Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. OBJECTIVE: To compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran. METHODS: This randomized controlled trial was done on 2- to 6-year-old children attending Koodakan Hospital in Bandar Abbas, southern Iran, in 2014. Patients were divided into three groups of montelukast, mometasone, and control group. Audiometry was done for all patients at baseline and four weeks after treatment. Patients were compared for treatment results. Data were analyzed using SPSS 21.0 software. RESULTS: A total of 143 children were included in the study. Mean age of the participants were 44.64 ± 18.03 months. There was no significant difference in treatment results in different treatment groups (p>0.05). CONCLUSION: Mometasone and montelukast are not effective and not recommended in treatment of otitis media with effusion in children. More studies are needed in this regard. TRIAL REGISTRATION: This study is registered at ClinicalTrials.gov with ClinicalTrials.gov Identifier: NCT02541760. FUNDING: The authors received financial support for this research from Hormozgan University of Medical Sciences.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.19082/4890

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Rahmati 2017, the risk of bias for allocation concealment (selection bias) was unclear because there was insufficient information about the sequence generation process.

    “Allocation concealment (selection bias) Unclear risk Insufficient information about the sequence generation process to permit judgement.”

    From Topical and oral steroids for otitis media with effusion (OME) in children (2023) · cites this paper as Rahmati 2017

    Section 2.4, “Randomization and intervention” (page unavailable), says participants were randomly assigned to three groups but gives no sequence-generation or allocation-concealment procedure. That supports the stated lack of information; the paper does not itself assess allocation concealment as having unclear risk of bias. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. [1]Simasek M Blandino DA Treatment of the common cold Am Fam Physician 2007 75 4 515 20 17323712
  2. [2]Coker TR Chan LS Newberry SJ Limbos MA Suttorp MJ Shekelle PG Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review JAMA 2010 304 19 2161 9 10.1001/jama.2010.1651 21081729 · DOI
  3. [3]Casselbrant ML Mandel EM Rockette HE Kurs-Lasky M Fall PA Bluestone CD Adenoidectomy for otitis media with effusion in 2–3-year-old children Int J Pediatr Otorhinolaryngol 2009 73 12 1718 24 10.1016/j.ijporl.2009.09.007 19819563 PMC2787742 · DOI
  4. [4]Thomas CL Simpson S Butler CC van der Voort JH Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children Cochrane Database Syst Rev 2006 3 CD001935 10.1002/14651858.CD001935.pub2 16855980 · DOI
  5. [5]Neck S American Academy of Family P, American Academy of O-H, American Academy of Pediatrics Subcommittee on Otitis Media With E Otitis media with effusion Pediatrics 2004 113 5 1412 29 15121966
  6. [6]Mandel EM Casselbrant ML Rockette HE Fireman P Kurs-Lasky M Bluestone CD Systemic steroid for chronic otitis media with effusion in children Pediatrics 2002 110 6 1071 80 12456902
  7. [7]Fireman P Effect of early or delayed insertion of tympanostomy tubes Curr Allergy Asthma Rep 2002 2 4 295 6 12044263
  8. [8]Butler CC Van Der Voort JH Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children Cochrane Database Syst Rev 2002 4 CD001935 10.1002/14651858.CD001935. 11034736 · DOI
  9. [9]Tapiainen T Kujala T Renko M Koivunen P Kontiokari T Kristo A Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial JAMA Pediatr 2014 168 7 635 41 10.1001/jamapediatrics.2013.5311 24797294 · DOI
  10. [10]Bhargava R Chakravarti A A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion Am J Otolaryngol 2014 35 6 766 70 10.1016/j.amjoto.2014.06.006 25151658 · DOI · Paper page
  11. [11]Ucar S Huseynov T Coban M Sarioglu S Serbetcioglu B Yalcin AD Montelukast is as effective as penicillin in treatment of acute otitis media: an experimental rat study Med Sci Monit Basic Res 2013 19 246 52 10.12659/MSMBR.889474 24048018 PMC3808231 · DOI
  12. [13]Leach AJ Morris PS Mathews JD Chronic Otitis Media Intervention Trial - One g. Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial BMC Pediatr 2008 8 23 10.1186/1471-2431-8-23 18513453 PMC2443129 · DOI
  13. [14]Daniel M Antibiotics for otitis media with effusion in children Clin Otolaryngol 2013 38 1 56 7 10.1111/coa.12069 23418968 · DOI
  14. [15]Van Zon A van der Heijden GJ van Dongen TM Burton MJ Schilder AG Antibiotics for otitis media with effusion in children Cochrane Database Syst Rev 2012 9 CD009163 10.1002/14651858.CD009163.pub2 22972136 · DOI
  15. [16]Wallace IF Berkman ND Lohr KN Harrison MF Kimple AJ Steiner MJ Surgical treatments for otitis media with effusion: a systematic review Pediatrics 2014 133 2 296 311 10.1542/peds.2013-3228 24394689 · DOI
  16. [17]Ertugay CK Cingi C Yaz A San T Ulusoy S Erdogmus N Effect of combination of montelukast and levocetirizine on otitis media with effusion: a prospective, placebo-controlled trial Acta Otolaryngol 2013 133 12 1266 72 10.3109/00016489.2013.824113 23972320 · DOI
  17. [18]Aynali G Yariktas M Yasan H Karahan N Baspinar S Tuz M The effects of methylprednisolone, montelukast and indomethacine in experimental otitis media with effusion Int J Pediatr Otorhinolaryngol 2011 75 1 15 9 10.1016/j.ijporl.2010.09.024 21036406 · DOI
  18. [19]Schoem SR Willard A Combs JT A prospective, randomized, placebo-controlled, double-blind study of montelukast’s effect on persistent middle ear effusion Ear Nose Throat J 2010 89 9 434 7 20859868
  19. [20]Combs JT The effect of montelukast sodium on the duration of effusion of otitis media Clin Pediatr (Phila) 2004 43 6 529 33 15248005

Cited by

Sorted by citations

Authors
Bagher Rahmati, M., Safdarian, F., Shiroui, B., Zare, S., & Sadeghi, N.
Affiliations
Hormozgan University of Medical Sciences (IR)
Corresponding author
Shiroui, Babak
Venue
Electronic Physician
Published
2017-07-25
Volume
9
Issue
7
Pages
4890-4894
ISSN
2008-5842 (ISSN-L)
OpenAlex
W2747925542
Cited by
5
References
1
Citations by year
2026: 1 · 2023: 2 · 2022: 1 · 2021: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Electronic physician (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Hormozgan University of Medical Sciences
Topics
  • Health Sciences › Medicine › Otorhinolaryngology › Ear Surgery and Otitis Media
  • Health Sciences › Health Professions › Emergency Medical Services › Pediatric health and respiratory diseases
  • Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
Keywords
otitis media with effusion, montelukast, children, leukotriene receptor antagonists, corticosteroid nasal spray, audiometry, treatment efficacy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review